Literature DB >> 436302

L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume.

J M Hansen, J Kampmann, S N Madsen, L Skovsted, S Solgaard, C Grytter, T Grontvedt, S N Rasmussen.   

Abstract

The effect of a daily dose of 150 micrograms l-thyroxine for one year was studied in forty-five patients with diffuse non-toxic goitre. Thyroid volume was evaluated by ultrasonic scanning. A decrease in the median value of the thyroid volume of about 20% was found after 3 months of therapy and no further change in the median value was observed in the following 9 months of treatment. About 50% of the patients showed a response to therapy and about 30% obtained normal size of the thyroid gland. Median value of the thyroid volume returned to pretreatment value 3 months after thyroxine therapy was stopped. A considerable increase in serum T4 and free T4 index was noted after 3 months of therapy and these elevated values persisted unaltered during the following 9 months of treatment. Serum T3 was studied before and after 3 months of thyroxine therapy in eleven of the patients. A small and insignificant increase in serum T3 and free T3 index was observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436302     DOI: 10.1111/j.1365-2265.1979.tb03027.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

2.  Nodular goiter: effects of surgery and thyroxine medication.

Authors:  K Westermark; C P Persson; H Johansson; F A Karlsson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?

Authors:  L Hegedüs; J M Hansen; D Veiergang; S Karstrup
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-28

4.  Effects of thyroxine on cell proliferation in human multinodular goiter: a study on growth of thyroid tissue transplanted to nude mice.

Authors:  S Smeds; H J Peter; H Gerber; E Jörtsö; S Lennquist; H Studer
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

5.  Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent.

Authors:  J D Wiener
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

6.  Iodine vs thyroxine. A changing concept of therapy in endemic goiter?

Authors:  G Hintze; J Köbberling
Journal:  Klin Wochenschr       Date:  1987-07-01

7.  Ultrasound scanning assessment of L-thyroxine treatment effectiveness in a group of children with diffuse goiter.

Authors:  C Regalbuto; A Belfiore; D Giuffrida; A Ippolito; R M Motta; L Sava
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

Review 8.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

9.  Radioiodine treatment for non-toxic goitre.

Authors:  Ulla Feldt-Rasmussen
Journal:  F1000 Med Rep       Date:  2009-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.